These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19536529)

  • 21. Low molecular weight heparin ('fragmin') in haemodialysis: is laboratory monitoring worthwhile?
    Sigüenza F; Maduell F; Perella M; Lopez-Menchero R; Grau E; Pastor E
    Nephrol Dial Transplant; 1995 Nov; 10(11):2163-4. PubMed ID: 8643198
    [No Abstract]   [Full Text] [Related]  

  • 22. Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.
    Koch P; Reinhold S; Busch C
    Contact Dermatitis; 2000 May; 42(5):278-9. PubMed ID: 10789845
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidelines are usually the safer road.
    Gjesdal K
    Cardiology; 2007; 107(4):373. PubMed ID: 17284897
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuous intravenous infusion of a low-molecular-weight heparin during allogenic haematopoietic stem-cell transplantation.
    Boeras A; Lambert C; Ferrant A; van den Neste E; Hermans C
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):735-7. PubMed ID: 18832921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hematoma of the abdominal wall secondary to use of low molecular weight heparin].
    Yusty Campo M; Lado Lado FL; Pérez Herbón M; Rodríguez Constenla I; Rodríguez López I
    An Med Interna; 2003 May; 20(5):273-4. PubMed ID: 12831308
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioequivalence of generic and branded subcutaneous enoxaparin: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects.
    Feng L; Shen-Tu J; Liu J; Chen J; Wu L; Huang M
    Clin Ther; 2009 Jul; 31(7):1559-67. PubMed ID: 19695405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Xa stability of diluted dalteparin for pediatric use.
    Goldenberg NA; Jacobson L; Hathaway H; Tripputi M; Primeaux J; Child J
    Ann Pharmacother; 2008 Apr; 42(4):511-5. PubMed ID: 18349310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcinosis of the cutis and subcutis: an unusual nonimmunologic adverse reaction to subcutaneous injections of low-molecular-weight calcium-containing heparins.
    Eich D; Scharffetter-Kochanek K; Weihrauch J; Krieg T; Hunzelmann N
    J Am Acad Dermatol; 2004 Feb; 50(2):210-4. PubMed ID: 14726874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed-type hypersensitivity to heparins: different patterns of cross-reactivity.
    Palacios Colom L; Alcántara Villar M; Luis Anguita Carazo J; Ruiz Villaverde R; Quiralte Enríquez J
    Contact Dermatitis; 2008 Dec; 59(6):375-7. PubMed ID: 19076893
    [No Abstract]   [Full Text] [Related]  

  • 30. Perioperative anticoagulant management.
    Grant PJ; Brotman DJ; Jaffer AK
    Med Clin North Am; 2009 Sep; 93(5):1105-21. PubMed ID: 19665623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of fatal pulmonary embolism raising questions about the dosing regimen for dalteparin in the very obese.
    Walden A; Levison R; Singh S; Keeling D
    Br J Haematol; 2008 Jul; 142(3):487-9. PubMed ID: 18477049
    [No Abstract]   [Full Text] [Related]  

  • 32. What are the lowest doses of low molecular weight heparin for effective and safe hemodialysis in different subgroups of patients?
    Sain M; Kovacic V; Radic J; Ljutic D; Jelicic I
    Ther Apher Dial; 2014 Apr; 18(2):208-9. PubMed ID: 24720413
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-molecular-weight heparin in pregnancy.
    Kittisupamongkol W
    Am J Obstet Gynecol; 2009 Sep; 201(3):e12; author reply e12. PubMed ID: 19439265
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.
    Gerotziafas GT; Dupont C; Spyropoulos AC; Hatmi M; Samama MM; Kiskinis D; Elalamy I
    Thromb Haemost; 2009 Jul; 102(1):42-8. PubMed ID: 19572066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nadroparine blunts lipopolysaccharide-induced hypothermia and behavioral depression in mice.
    Akyol C; Ozis E; Cakmak A; Akarsu ES; Kuzu MA
    J Invest Surg; 2008; 21(6):311-7. PubMed ID: 19160140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immediate type hypersensitivity after injection of nadroparin (Fraxiparin).
    Bekkenk MW; van Zuuren EJ
    Thromb Haemost; 2005 Sep; 94(3):673-4. PubMed ID: 16268488
    [No Abstract]   [Full Text] [Related]  

  • 37. [Warfarin or enoxaparin: the choice for the patient with venous thrombosis in the first month of treatment].
    Vorob'eva NM; Panchenko EP; Kirienko AI; Dobrovol'skiĭ AB; Titaeva EV; Ermolina OV; Balakhonova TV; Andriiashkin VV; Leont'ev SG
    Ter Arkh; 2009; 81(9):57-61. PubMed ID: 19827655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of heparinized versus non-heparinized syringes for measurements of the pleural fluid pH.
    Bou-Khalil PK; Jamaleddine GW; Debek AH; El-Khatib MF
    Respiration; 2007; 74(6):659-62. PubMed ID: 17675830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology of anticoagulation for hemodialysis patients: survey of 842 cases in seven hemodialysis centers].
    Sun XF; Xiao Q; Wang Y; Hao LR; Lin HL; Zhang ZM; Li JJ; Chen XM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):577-81. PubMed ID: 19595154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subcutaneous heparin for prophylaxis of venous thromboembolism in deep brain stimulation surgery: evidence from a decision analysis.
    Bauman JA; Church E; Halpern CH; Danish SF; Zaghloul KA; Jaggi JL; Stein SC; Baltuch GH
    Neurosurgery; 2009 Aug; 65(2):276-80; discussion 280. PubMed ID: 19625905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.